Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Igc Pharma Inc (IGC)

Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Igc Pharma Inc 10224 FALLS ROAD POTOMAC MD 20854 USA

https://igcpharma.com Employees: 70 P: 301-983-0998

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

IGC Pharma Inc. develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. IGC Pharma Inc., formerly known as India Globalization Capital Inc., is based in POTOMAC, Md.

Key Statistics

Overview:

Market Capitalization, $K 26,354
Enterprise Value, $K 26,074
Shares Outstanding, K 95,038
Float, K 72,552
% Float 76.34%
Short Interest, K 598
Short Float 0.63%
Days to Cover 1.37
Short Volume Ratio 0.41
% of Insider Shareholders 23.66%
% of Institutional Shareholders 3.87%

Financials:

Annual Sales, $ 1,270 K
Annual Net Income, $ -7,120 K
Last Quarter Sales, $ 190 K
Last Quarter Net Income, $ -1,820 K
EBIT, $ -8,100 K
EBITDA, $ -7,480 K

Growth:

1-Year Return -1.70%
3-Year Return -27.94%
5-Year Return -82.99%
5-Year Revenue Growth -68.80%
5-Year Earnings Growth 47.06%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.02 on 11/14/25
Next Earnings Date 02/27/26
Earnings Per Share ttm -0.07
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 0.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IGC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -96.54%
Return-on-Assets % -72.74%
Profit Margin % -560.63%
Debt/Equity 0.02
Price/Sales 20.73
Price/Cash Flow N/A
Price/Book 3.18
Book Value/Share 0.09
Interest Coverage -0.61
60-Month Beta 0.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar